Abbott may look to expand the geographic footprint of its medical device business, CFO Thomas Freyman says. Abbott (NYSE:ABT) may look to expand the geographic footprint of its medical device footprint and has no plans to shed its branded generic pharmaceuticals arm, CFO Thomas Freyman said yesterday. Speaking at the annual Deutsche Bank Healthcare Conference in Boston yesterday, Freyman said the branded generics business is a key plank it its platform for emerging markets.
Help employers find you! Check out all the jobs and post your resume.
